VETRANO, ERICA
 Distribuzione geografica
Continente #
EU - Europa 2.594
AS - Asia 1.241
NA - Nord America 1.027
SA - Sud America 160
AF - Africa 18
Totale 5.040
Nazione #
RU - Federazione Russa 2.075
US - Stati Uniti d'America 999
SG - Singapore 378
CN - Cina 260
VN - Vietnam 225
IT - Italia 194
HK - Hong Kong 183
IE - Irlanda 132
BR - Brasile 127
KR - Corea 70
IN - India 52
DE - Germania 50
GB - Regno Unito 36
FR - Francia 24
JP - Giappone 18
MX - Messico 15
NL - Olanda 11
PL - Polonia 10
AR - Argentina 8
AT - Austria 8
FI - Finlandia 8
CA - Canada 7
SE - Svezia 7
TR - Turchia 7
BD - Bangladesh 6
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PK - Pakistan 6
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CH - Svizzera 4
PT - Portogallo 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
SA - Arabia Saudita 3
BE - Belgio 2
CZ - Repubblica Ceca 2
ES - Italia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PY - Paraguay 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.040
Città #
Moscow 747
San Jose 218
Singapore 195
Hong Kong 176
Dublin 126
Santa Clara 103
Chandler 81
Ashburn 78
Ho Chi Minh City 75
Hefei 70
Seoul 70
The Dalles 62
Naples 52
Hanoi 50
New York 43
Bengaluru 30
Los Angeles 30
Dallas 28
Beijing 26
Da Nang 17
Munich 17
São Paulo 13
Orem 12
Cambridge 11
Princeton 11
Roxbury 11
Caserta 10
Falkenstein 10
Atlanta 8
Haiphong 8
Memphis 8
Salerno 8
Chennai 7
Hải Dương 7
Liveri 7
Bremen 6
Hillsboro 6
Mexico City 6
Milan 6
Stockholm 6
Tokyo 6
Warsaw 6
Amsterdam 5
Can Tho 5
Chicago 5
Denver 5
Florence 5
Frankfurt am Main 5
Lahore 5
Vienna 5
Baku 4
Belo Horizonte 4
Biên Hòa 4
Brasília 4
Brooklyn 4
Damietta 4
Des Moines 4
Helsinki 4
Houston 4
Istanbul 4
Johannesburg 4
Lisbon 4
Manchester 4
Paris 4
Seattle 4
Yên Bái 4
Zurich 4
Andover 3
Bexley 3
Boydton 3
Chengdu 3
Council Bluffs 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Ha Long 3
La Paz 3
Lappeenranta 3
Lima 3
Manaus 3
Mumbai 3
Nha Trang 3
Norwalk 3
Nuremberg 3
Phoenix 3
Rio de Janeiro 3
Rome 3
San Francisco 3
San José 3
Shenzhen 3
Terzigno 3
Toronto 3
Addis Ababa 2
An Giang Province 2
Andria 2
Asunción 2
Athens 2
Avellino 2
Banda Aceh 2
Bari 2
Totale 2.666
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 193
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 158
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
HCC and molecular targeting therapies: Back to the future 135
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 126
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 124
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 124
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 124
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 124
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 123
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 123
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 118
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 116
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 115
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 114
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 114
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 111
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 110
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 109
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 104
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 98
null 93
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 92
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 88
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 87
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 87
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 85
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 79
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 79
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 70
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 70
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 51
Totale 5.107
Categoria #
all - tutte 16.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202294 1 0 0 17 20 6 4 2 3 2 11 28
2022/2023292 17 15 8 17 35 16 4 22 133 8 5 12
2023/2024234 31 11 6 18 47 36 4 9 5 15 22 30
2024/2025712 6 13 3 11 103 76 102 68 133 65 59 73
2025/20263.761 193 234 199 118 324 1.909 295 190 125 77 57 40
Totale 5.107